In patients with lung cancer, prostate cancer or colorectal carcinoma, blood PTX3 levels resulted elevated compared respectively to healthy subjects, patients with prostatic inflammation or colorectal polyps (50–52). This evidence concerns the gene PTX3 and prostate cancer.